Global Inactivated Porcine Parvovirus Vaccine Production, Demand and Key Producers, 2022-2028
The porcine parvovirus inactivated vaccine is used for preventing a porcine parvovirus disease caused by a porcine parvovirus.
This report studies the global Inactivated Porcine Parvovirus Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Inactivated Porcine Parvovirus Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inactivated Porcine Parvovirus Vaccine that contribute to its increasing demand across many markets.
The global Inactivated Porcine Parvovirus Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Inactivated Porcine Parvovirus Vaccine total production and demand, 2017-2028, (M Doses)
Global Inactivated Porcine Parvovirus Vaccine total production value, 2017-2028, (USD Million)
Global Inactivated Porcine Parvovirus Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (M Doses)
Global Inactivated Porcine Parvovirus Vaccine consumption by region & country, CAGR, 2017-2028 & (M Doses)
U.S. VS China: Inactivated Porcine Parvovirus Vaccine domestic production, consumption, key domestic manufacturers and share
Global Inactivated Porcine Parvovirus Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (M Doses)
Global Inactivated Porcine Parvovirus Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (M Doses)
Global Inactivated Porcine Parvovirus Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (M Doses)
This reports profiles key players in the global Inactivated Porcine Parvovirus Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Inactivated Porcine Parvovirus Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inactivated Porcine Parvovirus Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (US$/K Doses) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Inactivated Porcine Parvovirus Vaccine Market, By Region:
1. How big is the global Inactivated Porcine Parvovirus Vaccine market?
2. What is the demand of the global Inactivated Porcine Parvovirus Vaccine market?
3. What is the year over year growth of the global Inactivated Porcine Parvovirus Vaccine market?
4. What is the production and production value of the global Inactivated Porcine Parvovirus Vaccine market?
5. Who are the key producers in the global Inactivated Porcine Parvovirus Vaccine market?
6. What are the growth factors driving the market demand?
This report studies the global Inactivated Porcine Parvovirus Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Inactivated Porcine Parvovirus Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inactivated Porcine Parvovirus Vaccine that contribute to its increasing demand across many markets.
The global Inactivated Porcine Parvovirus Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Inactivated Porcine Parvovirus Vaccine total production and demand, 2017-2028, (M Doses)
Global Inactivated Porcine Parvovirus Vaccine total production value, 2017-2028, (USD Million)
Global Inactivated Porcine Parvovirus Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (M Doses)
Global Inactivated Porcine Parvovirus Vaccine consumption by region & country, CAGR, 2017-2028 & (M Doses)
U.S. VS China: Inactivated Porcine Parvovirus Vaccine domestic production, consumption, key domestic manufacturers and share
Global Inactivated Porcine Parvovirus Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (M Doses)
Global Inactivated Porcine Parvovirus Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (M Doses)
Global Inactivated Porcine Parvovirus Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (M Doses)
This reports profiles key players in the global Inactivated Porcine Parvovirus Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Inactivated Porcine Parvovirus Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inactivated Porcine Parvovirus Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (US$/K Doses) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Inactivated Porcine Parvovirus Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- <107.0 TCID50/mL
- ?107.0 TCID50/mL
- Sows
- Gilts
- Boars
- Merck Animal Health
- HIPRA
- Zoetis
- Ceva
- Bioveta
- Boehringer Ingelheim
- Harbin Pharmaceutical Group
- Wuhan Keqian Biology
- DHN
- China Animal Husbandy Industry
- Qilu Animal Health Products Factorys
- Shandong HuaHong Biological Engineering
- Shanghai Hile Biological
- Liaoning Yikang Biological
- Jilin Zhengye Biological Product
1. How big is the global Inactivated Porcine Parvovirus Vaccine market?
2. What is the demand of the global Inactivated Porcine Parvovirus Vaccine market?
3. What is the year over year growth of the global Inactivated Porcine Parvovirus Vaccine market?
4. What is the production and production value of the global Inactivated Porcine Parvovirus Vaccine market?
5. Who are the key producers in the global Inactivated Porcine Parvovirus Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Inactivated Porcine Parvovirus Vaccine Introduction
1.2 World Inactivated Porcine Parvovirus Vaccine Supply & Forecast
1.2.1 World Inactivated Porcine Parvovirus Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Inactivated Porcine Parvovirus Vaccine Production (2017-2028)
1.2.3 World Inactivated Porcine Parvovirus Vaccine Pricing Trends (2017-2028)
1.3 World Inactivated Porcine Parvovirus Vaccine Production by Region
1.3.1 World Inactivated Porcine Parvovirus Vaccine Production Value by Region (2017-2028)
1.3.2 World Inactivated Porcine Parvovirus Vaccine Production by Region (2017-2028)
1.3.3 World Inactivated Porcine Parvovirus Vaccine Average Price by Region (2017-2028)
1.3.4 North America Inactivated Porcine Parvovirus Vaccine Production (2017-2028)
1.3.5 Europe Inactivated Porcine Parvovirus Vaccine Production (2017-2028)
1.3.6 China Inactivated Porcine Parvovirus Vaccine Production (2017-2028)
1.3.7 Japan Inactivated Porcine Parvovirus Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Inactivated Porcine Parvovirus Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Inactivated Porcine Parvovirus Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Inactivated Porcine Parvovirus Vaccine Demand (2017-2028)
2.2 World Inactivated Porcine Parvovirus Vaccine Consumption by Region
2.2.1 World Inactivated Porcine Parvovirus Vaccine Consumption by Region (2017-2022)
2.2.2 World Inactivated Porcine Parvovirus Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028)
2.4 China Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028)
2.5 Europe Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028)
2.6 Japan Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028)
2.7 South Korea Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028)
2.8 ASEAN Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028)
2.9 India Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028)
3 WORLD INACTIVATED PORCINE PARVOVIRUS VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Inactivated Porcine Parvovirus Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Inactivated Porcine Parvovirus Vaccine Production by Manufacturer (2017-2022)
3.3 World Inactivated Porcine Parvovirus Vaccine Average Price by Manufacturer (2017-2022)
3.4 Inactivated Porcine Parvovirus Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Inactivated Porcine Parvovirus Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Inactivated Porcine Parvovirus Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Inactivated Porcine Parvovirus Vaccine in 2021
3.6 Inactivated Porcine Parvovirus Vaccine Market: Overall Company Footprint Analysis
3.6.1 Inactivated Porcine Parvovirus Vaccine Market: Region Footprint
3.6.2 Inactivated Porcine Parvovirus Vaccine Market: Company Product Type Footprint
3.6.3 Inactivated Porcine Parvovirus Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Inactivated Porcine Parvovirus Vaccine Production Value Comparison
4.1.1 United States VS China: Inactivated Porcine Parvovirus Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Inactivated Porcine Parvovirus Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Inactivated Porcine Parvovirus Vaccine Production Comparison
4.2.1 United States VS China: Inactivated Porcine Parvovirus Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Inactivated Porcine Parvovirus Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Inactivated Porcine Parvovirus Vaccine Consumption Comparison
4.3.1 United States VS China: Inactivated Porcine Parvovirus Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Inactivated Porcine Parvovirus Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Inactivated Porcine Parvovirus Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Inactivated Porcine Parvovirus Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Inactivated Porcine Parvovirus Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Inactivated Porcine Parvovirus Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Inactivated Porcine Parvovirus Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Inactivated Porcine Parvovirus Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Inactivated Porcine Parvovirus Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Inactivated Porcine Parvovirus Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Inactivated Porcine Parvovirus Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Inactivated Porcine Parvovirus Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Inactivated Porcine Parvovirus Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Inactivated Porcine Parvovirus Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Inactivated Porcine Parvovirus Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 <107.0 TCID50/mL
5.2.2 ?107.0 TCID50/mL
5.3 Market Segment by Type
5.3.1 World Inactivated Porcine Parvovirus Vaccine Production by Type (2017-2028)
5.3.2 World Inactivated Porcine Parvovirus Vaccine Production Value by Type (2017-2028)
5.3.3 World Inactivated Porcine Parvovirus Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Inactivated Porcine Parvovirus Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Sows
6.2.2 Gilts
6.2.3 Boars
6.3 Market Segment by Application
6.3.1 World Inactivated Porcine Parvovirus Vaccine Production by Application (2017-2028)
6.3.2 World Inactivated Porcine Parvovirus Vaccine Production Value by Application (2017-2028)
6.3.3 World Inactivated Porcine Parvovirus Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Merck Animal Health
7.1.1 Merck Animal Health Details
7.1.2 Merck Animal Health Major Business
7.1.3 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Product and Services
7.1.4 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Merck Animal Health Recent Developments/Updates
7.1.6 Merck Animal Health Competitive Strengths & Weaknesses
7.2 HIPRA
7.2.1 HIPRA Details
7.2.2 HIPRA Major Business
7.2.3 HIPRA Inactivated Porcine Parvovirus Vaccine Product and Services
7.2.4 HIPRA Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 HIPRA Recent Developments/Updates
7.2.6 HIPRA Competitive Strengths & Weaknesses
7.3 Zoetis
7.3.1 Zoetis Details
7.3.2 Zoetis Major Business
7.3.3 Zoetis Inactivated Porcine Parvovirus Vaccine Product and Services
7.3.4 Zoetis Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Zoetis Recent Developments/Updates
7.3.6 Zoetis Competitive Strengths & Weaknesses
7.4 Ceva
7.4.1 Ceva Details
7.4.2 Ceva Major Business
7.4.3 Ceva Inactivated Porcine Parvovirus Vaccine Product and Services
7.4.4 Ceva Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Ceva Recent Developments/Updates
7.4.6 Ceva Competitive Strengths & Weaknesses
7.5 Bioveta
7.5.1 Bioveta Details
7.5.2 Bioveta Major Business
7.5.3 Bioveta Inactivated Porcine Parvovirus Vaccine Product and Services
7.5.4 Bioveta Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Bioveta Recent Developments/Updates
7.5.6 Bioveta Competitive Strengths & Weaknesses
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Details
7.6.2 Boehringer Ingelheim Major Business
7.6.3 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Product and Services
7.6.4 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Boehringer Ingelheim Recent Developments/Updates
7.6.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.7 Harbin Pharmaceutical Group
7.7.1 Harbin Pharmaceutical Group Details
7.7.2 Harbin Pharmaceutical Group Major Business
7.7.3 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Product and Services
7.7.4 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.7.6 Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
7.8 Wuhan Keqian Biology
7.8.1 Wuhan Keqian Biology Details
7.8.2 Wuhan Keqian Biology Major Business
7.8.3 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Product and Services
7.8.4 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Wuhan Keqian Biology Recent Developments/Updates
7.8.6 Wuhan Keqian Biology Competitive Strengths & Weaknesses
7.9 DHN
7.9.1 DHN Details
7.9.2 DHN Major Business
7.9.3 DHN Inactivated Porcine Parvovirus Vaccine Product and Services
7.9.4 DHN Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 DHN Recent Developments/Updates
7.9.6 DHN Competitive Strengths & Weaknesses
7.10 China Animal Husbandy Industry
7.10.1 China Animal Husbandy Industry Details
7.10.2 China Animal Husbandy Industry Major Business
7.10.3 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Product and Services
7.10.4 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 China Animal Husbandy Industry Recent Developments/Updates
7.10.6 China Animal Husbandy Industry Competitive Strengths & Weaknesses
7.11 Qilu Animal Health Products Factorys
7.11.1 Qilu Animal Health Products Factorys Details
7.11.2 Qilu Animal Health Products Factorys Major Business
7.11.3 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Product and Services
7.11.4 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Qilu Animal Health Products Factorys Recent Developments/Updates
7.11.6 Qilu Animal Health Products Factorys Competitive Strengths & Weaknesses
7.12 Shandong HuaHong Biological Engineering
7.12.1 Shandong HuaHong Biological Engineering Details
7.12.2 Shandong HuaHong Biological Engineering Major Business
7.12.3 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Product and Services
7.12.4 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Shandong HuaHong Biological Engineering Recent Developments/Updates
7.12.6 Shandong HuaHong Biological Engineering Competitive Strengths & Weaknesses
7.13 Shanghai Hile Biological
7.13.1 Shanghai Hile Biological Details
7.13.2 Shanghai Hile Biological Major Business
7.13.3 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Product and Services
7.13.4 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Shanghai Hile Biological Recent Developments/Updates
7.13.6 Shanghai Hile Biological Competitive Strengths & Weaknesses
7.14 Liaoning Yikang Biological
7.14.1 Liaoning Yikang Biological Details
7.14.2 Liaoning Yikang Biological Major Business
7.14.3 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Product and Services
7.14.4 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Liaoning Yikang Biological Recent Developments/Updates
7.14.6 Liaoning Yikang Biological Competitive Strengths & Weaknesses
7.15 Jilin Zhengye Biological Product
7.15.1 Jilin Zhengye Biological Product Details
7.15.2 Jilin Zhengye Biological Product Major Business
7.15.3 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Product and Services
7.15.4 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Jilin Zhengye Biological Product Recent Developments/Updates
7.15.6 Jilin Zhengye Biological Product Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Inactivated Porcine Parvovirus Vaccine and Key Manufacturers
8.2 Inactivated Porcine Parvovirus Vaccine Manufacturing Costs
8.3 Inactivated Porcine Parvovirus Vaccine Production Process
8.4 Inactivated Porcine Parvovirus Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Inactivated Porcine Parvovirus Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Inactivated Porcine Parvovirus Vaccine Typical Distributors
9.3 Inactivated Porcine Parvovirus Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Inactivated Porcine Parvovirus Vaccine Introduction
1.2 World Inactivated Porcine Parvovirus Vaccine Supply & Forecast
1.2.1 World Inactivated Porcine Parvovirus Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Inactivated Porcine Parvovirus Vaccine Production (2017-2028)
1.2.3 World Inactivated Porcine Parvovirus Vaccine Pricing Trends (2017-2028)
1.3 World Inactivated Porcine Parvovirus Vaccine Production by Region
1.3.1 World Inactivated Porcine Parvovirus Vaccine Production Value by Region (2017-2028)
1.3.2 World Inactivated Porcine Parvovirus Vaccine Production by Region (2017-2028)
1.3.3 World Inactivated Porcine Parvovirus Vaccine Average Price by Region (2017-2028)
1.3.4 North America Inactivated Porcine Parvovirus Vaccine Production (2017-2028)
1.3.5 Europe Inactivated Porcine Parvovirus Vaccine Production (2017-2028)
1.3.6 China Inactivated Porcine Parvovirus Vaccine Production (2017-2028)
1.3.7 Japan Inactivated Porcine Parvovirus Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Inactivated Porcine Parvovirus Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Inactivated Porcine Parvovirus Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Inactivated Porcine Parvovirus Vaccine Demand (2017-2028)
2.2 World Inactivated Porcine Parvovirus Vaccine Consumption by Region
2.2.1 World Inactivated Porcine Parvovirus Vaccine Consumption by Region (2017-2022)
2.2.2 World Inactivated Porcine Parvovirus Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028)
2.4 China Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028)
2.5 Europe Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028)
2.6 Japan Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028)
2.7 South Korea Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028)
2.8 ASEAN Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028)
2.9 India Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028)
3 WORLD INACTIVATED PORCINE PARVOVIRUS VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Inactivated Porcine Parvovirus Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Inactivated Porcine Parvovirus Vaccine Production by Manufacturer (2017-2022)
3.3 World Inactivated Porcine Parvovirus Vaccine Average Price by Manufacturer (2017-2022)
3.4 Inactivated Porcine Parvovirus Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Inactivated Porcine Parvovirus Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Inactivated Porcine Parvovirus Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Inactivated Porcine Parvovirus Vaccine in 2021
3.6 Inactivated Porcine Parvovirus Vaccine Market: Overall Company Footprint Analysis
3.6.1 Inactivated Porcine Parvovirus Vaccine Market: Region Footprint
3.6.2 Inactivated Porcine Parvovirus Vaccine Market: Company Product Type Footprint
3.6.3 Inactivated Porcine Parvovirus Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Inactivated Porcine Parvovirus Vaccine Production Value Comparison
4.1.1 United States VS China: Inactivated Porcine Parvovirus Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Inactivated Porcine Parvovirus Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Inactivated Porcine Parvovirus Vaccine Production Comparison
4.2.1 United States VS China: Inactivated Porcine Parvovirus Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Inactivated Porcine Parvovirus Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Inactivated Porcine Parvovirus Vaccine Consumption Comparison
4.3.1 United States VS China: Inactivated Porcine Parvovirus Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Inactivated Porcine Parvovirus Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Inactivated Porcine Parvovirus Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Inactivated Porcine Parvovirus Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Inactivated Porcine Parvovirus Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Inactivated Porcine Parvovirus Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Inactivated Porcine Parvovirus Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Inactivated Porcine Parvovirus Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Inactivated Porcine Parvovirus Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Inactivated Porcine Parvovirus Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Inactivated Porcine Parvovirus Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Inactivated Porcine Parvovirus Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Inactivated Porcine Parvovirus Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Inactivated Porcine Parvovirus Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Inactivated Porcine Parvovirus Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 <107.0 TCID50/mL
5.2.2 ?107.0 TCID50/mL
5.3 Market Segment by Type
5.3.1 World Inactivated Porcine Parvovirus Vaccine Production by Type (2017-2028)
5.3.2 World Inactivated Porcine Parvovirus Vaccine Production Value by Type (2017-2028)
5.3.3 World Inactivated Porcine Parvovirus Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Inactivated Porcine Parvovirus Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Sows
6.2.2 Gilts
6.2.3 Boars
6.3 Market Segment by Application
6.3.1 World Inactivated Porcine Parvovirus Vaccine Production by Application (2017-2028)
6.3.2 World Inactivated Porcine Parvovirus Vaccine Production Value by Application (2017-2028)
6.3.3 World Inactivated Porcine Parvovirus Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Merck Animal Health
7.1.1 Merck Animal Health Details
7.1.2 Merck Animal Health Major Business
7.1.3 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Product and Services
7.1.4 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Merck Animal Health Recent Developments/Updates
7.1.6 Merck Animal Health Competitive Strengths & Weaknesses
7.2 HIPRA
7.2.1 HIPRA Details
7.2.2 HIPRA Major Business
7.2.3 HIPRA Inactivated Porcine Parvovirus Vaccine Product and Services
7.2.4 HIPRA Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 HIPRA Recent Developments/Updates
7.2.6 HIPRA Competitive Strengths & Weaknesses
7.3 Zoetis
7.3.1 Zoetis Details
7.3.2 Zoetis Major Business
7.3.3 Zoetis Inactivated Porcine Parvovirus Vaccine Product and Services
7.3.4 Zoetis Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Zoetis Recent Developments/Updates
7.3.6 Zoetis Competitive Strengths & Weaknesses
7.4 Ceva
7.4.1 Ceva Details
7.4.2 Ceva Major Business
7.4.3 Ceva Inactivated Porcine Parvovirus Vaccine Product and Services
7.4.4 Ceva Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Ceva Recent Developments/Updates
7.4.6 Ceva Competitive Strengths & Weaknesses
7.5 Bioveta
7.5.1 Bioveta Details
7.5.2 Bioveta Major Business
7.5.3 Bioveta Inactivated Porcine Parvovirus Vaccine Product and Services
7.5.4 Bioveta Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Bioveta Recent Developments/Updates
7.5.6 Bioveta Competitive Strengths & Weaknesses
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Details
7.6.2 Boehringer Ingelheim Major Business
7.6.3 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Product and Services
7.6.4 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Boehringer Ingelheim Recent Developments/Updates
7.6.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.7 Harbin Pharmaceutical Group
7.7.1 Harbin Pharmaceutical Group Details
7.7.2 Harbin Pharmaceutical Group Major Business
7.7.3 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Product and Services
7.7.4 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.7.6 Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
7.8 Wuhan Keqian Biology
7.8.1 Wuhan Keqian Biology Details
7.8.2 Wuhan Keqian Biology Major Business
7.8.3 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Product and Services
7.8.4 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Wuhan Keqian Biology Recent Developments/Updates
7.8.6 Wuhan Keqian Biology Competitive Strengths & Weaknesses
7.9 DHN
7.9.1 DHN Details
7.9.2 DHN Major Business
7.9.3 DHN Inactivated Porcine Parvovirus Vaccine Product and Services
7.9.4 DHN Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 DHN Recent Developments/Updates
7.9.6 DHN Competitive Strengths & Weaknesses
7.10 China Animal Husbandy Industry
7.10.1 China Animal Husbandy Industry Details
7.10.2 China Animal Husbandy Industry Major Business
7.10.3 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Product and Services
7.10.4 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 China Animal Husbandy Industry Recent Developments/Updates
7.10.6 China Animal Husbandy Industry Competitive Strengths & Weaknesses
7.11 Qilu Animal Health Products Factorys
7.11.1 Qilu Animal Health Products Factorys Details
7.11.2 Qilu Animal Health Products Factorys Major Business
7.11.3 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Product and Services
7.11.4 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Qilu Animal Health Products Factorys Recent Developments/Updates
7.11.6 Qilu Animal Health Products Factorys Competitive Strengths & Weaknesses
7.12 Shandong HuaHong Biological Engineering
7.12.1 Shandong HuaHong Biological Engineering Details
7.12.2 Shandong HuaHong Biological Engineering Major Business
7.12.3 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Product and Services
7.12.4 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Shandong HuaHong Biological Engineering Recent Developments/Updates
7.12.6 Shandong HuaHong Biological Engineering Competitive Strengths & Weaknesses
7.13 Shanghai Hile Biological
7.13.1 Shanghai Hile Biological Details
7.13.2 Shanghai Hile Biological Major Business
7.13.3 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Product and Services
7.13.4 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Shanghai Hile Biological Recent Developments/Updates
7.13.6 Shanghai Hile Biological Competitive Strengths & Weaknesses
7.14 Liaoning Yikang Biological
7.14.1 Liaoning Yikang Biological Details
7.14.2 Liaoning Yikang Biological Major Business
7.14.3 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Product and Services
7.14.4 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Liaoning Yikang Biological Recent Developments/Updates
7.14.6 Liaoning Yikang Biological Competitive Strengths & Weaknesses
7.15 Jilin Zhengye Biological Product
7.15.1 Jilin Zhengye Biological Product Details
7.15.2 Jilin Zhengye Biological Product Major Business
7.15.3 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Product and Services
7.15.4 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Jilin Zhengye Biological Product Recent Developments/Updates
7.15.6 Jilin Zhengye Biological Product Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Inactivated Porcine Parvovirus Vaccine and Key Manufacturers
8.2 Inactivated Porcine Parvovirus Vaccine Manufacturing Costs
8.3 Inactivated Porcine Parvovirus Vaccine Production Process
8.4 Inactivated Porcine Parvovirus Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Inactivated Porcine Parvovirus Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Inactivated Porcine Parvovirus Vaccine Typical Distributors
9.3 Inactivated Porcine Parvovirus Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Inactivated Porcine Parvovirus Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Inactivated Porcine Parvovirus Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Inactivated Porcine Parvovirus Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Inactivated Porcine Parvovirus Vaccine Production by Region (2017-2022) & (M Doses)
Table 7. World Inactivated Porcine Parvovirus Vaccine Production by Region (2023-2028) & (M Doses)
Table 8. World Inactivated Porcine Parvovirus Vaccine Production Market Share by Region (2017-2022)
Table 9. World Inactivated Porcine Parvovirus Vaccine Production Market Share by Region (2023-2028)
Table 10. World Inactivated Porcine Parvovirus Vaccine Average Price by Region (2017-2022) & (US$/K Doses)
Table 11. World Inactivated Porcine Parvovirus Vaccine Average Price by Region (2023-2028) & (US$/K Doses)
Table 12. Inactivated Porcine Parvovirus Vaccine Major Market Trends
Table 13. World Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (M Doses)
Table 14. World Inactivated Porcine Parvovirus Vaccine Consumption by Region (2017-2022) & (M Doses)
Table 15. World Inactivated Porcine Parvovirus Vaccine Consumption Forecast by Region (2023-2028) & (M Doses)
Table 16. World Inactivated Porcine Parvovirus Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Inactivated Porcine Parvovirus Vaccine Producers in 2021
Table 18. World Inactivated Porcine Parvovirus Vaccine Production by Manufacturer (2017-2022) & (M Doses)
Table 19. Production Market Share of Key Inactivated Porcine Parvovirus Vaccine Producers in 2021
Table 20. World Inactivated Porcine Parvovirus Vaccine Average Price by Manufacturer (2017-2022) & (US$/K Doses)
Table 21. Global Inactivated Porcine Parvovirus Vaccine Company Evaluation Quadrant
Table 22. World Inactivated Porcine Parvovirus Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Inactivated Porcine Parvovirus Vaccine Production Site of Key Manufacturer
Table 24. Inactivated Porcine Parvovirus Vaccine Market: Company Product Type Footprint
Table 25. Inactivated Porcine Parvovirus Vaccine Market: Company Product Application Footprint
Table 26. Inactivated Porcine Parvovirus Vaccine Competitive Factors
Table 27. Inactivated Porcine Parvovirus Vaccine New Entrant and Capacity Expansion Plans
Table 28. Inactivated Porcine Parvovirus Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Inactivated Porcine Parvovirus Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Inactivated Porcine Parvovirus Vaccine Production Comparison, (2017 & 2021 & 2028) & (M Doses)
Table 31. United States VS China Inactivated Porcine Parvovirus Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (M Doses)
Table 32. Major Manufacturer of Inactivated Porcine Parvovirus Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Inactivated Porcine Parvovirus Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Inactivated Porcine Parvovirus Vaccine Production by Domestic Manufacturer, (2017-2022) & (M Doses)
Table 36. United States Inactivated Porcine Parvovirus Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Inactivated Porcine Parvovirus Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Inactivated Porcine Parvovirus Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Inactivated Porcine Parvovirus Vaccine Production by Domestic Manufacturer, (2017-2022) & (M Doses)
Table 41. China Inactivated Porcine Parvovirus Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Inactivated Porcine Parvovirus Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Inactivated Porcine Parvovirus Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Inactivated Porcine Parvovirus Vaccine Production by Domestic Manufacturer, (2017-2022) & (M Doses)
Table 46. Rest of World Inactivated Porcine Parvovirus Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Inactivated Porcine Parvovirus Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Inactivated Porcine Parvovirus Vaccine Production by Type (2017-2022) & (M Doses)
Table 49. World Inactivated Porcine Parvovirus Vaccine Production by Type (2023-2028) & (M Doses)
Table 50. World Inactivated Porcine Parvovirus Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Inactivated Porcine Parvovirus Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Inactivated Porcine Parvovirus Vaccine Average Price by Type (2017-2022) & (US$/K Doses)
Table 53. World Inactivated Porcine Parvovirus Vaccine Average Price by Type (2023-2028) & (US$/K Doses)
Table 54. World Inactivated Porcine Parvovirus Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Inactivated Porcine Parvovirus Vaccine Production by Application (2017-2022) & (M Doses)
Table 56. World Inactivated Porcine Parvovirus Vaccine Production by Application (2023-2028) & (M Doses)
Table 57. World Inactivated Porcine Parvovirus Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Inactivated Porcine Parvovirus Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Inactivated Porcine Parvovirus Vaccine Average Price by Application (2017-2022) & (US$/K Doses)
Table 60. World Inactivated Porcine Parvovirus Vaccine Average Price by Application (2023-2028) & (US$/K Doses)
Table 61. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 62. Merck Animal Health Major Business
Table 63. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Product and Services
Table 64. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Merck Animal Health Recent Developments/Updates
Table 66. Merck Animal Health Competitive Strengths & Weaknesses
Table 67. HIPRA Basic Information, Manufacturing Base and Competitors
Table 68. HIPRA Major Business
Table 69. HIPRA Inactivated Porcine Parvovirus Vaccine Product and Services
Table 70. HIPRA Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. HIPRA Recent Developments/Updates
Table 72. HIPRA Competitive Strengths & Weaknesses
Table 73. Zoetis Basic Information, Manufacturing Base and Competitors
Table 74. Zoetis Major Business
Table 75. Zoetis Inactivated Porcine Parvovirus Vaccine Product and Services
Table 76. Zoetis Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Zoetis Recent Developments/Updates
Table 78. Zoetis Competitive Strengths & Weaknesses
Table 79. Ceva Basic Information, Manufacturing Base and Competitors
Table 80. Ceva Major Business
Table 81. Ceva Inactivated Porcine Parvovirus Vaccine Product and Services
Table 82. Ceva Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Ceva Recent Developments/Updates
Table 84. Ceva Competitive Strengths & Weaknesses
Table 85. Bioveta Basic Information, Manufacturing Base and Competitors
Table 86. Bioveta Major Business
Table 87. Bioveta Inactivated Porcine Parvovirus Vaccine Product and Services
Table 88. Bioveta Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Bioveta Recent Developments/Updates
Table 90. Bioveta Competitive Strengths & Weaknesses
Table 91. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 92. Boehringer Ingelheim Major Business
Table 93. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Product and Services
Table 94. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Boehringer Ingelheim Recent Developments/Updates
Table 96. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 97. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 98. Harbin Pharmaceutical Group Major Business
Table 99. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Product and Services
Table 100. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Harbin Pharmaceutical Group Recent Developments/Updates
Table 102. Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
Table 103. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 104. Wuhan Keqian Biology Major Business
Table 105. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Product and Services
Table 106. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Wuhan Keqian Biology Recent Developments/Updates
Table 108. Wuhan Keqian Biology Competitive Strengths & Weaknesses
Table 109. DHN Basic Information, Manufacturing Base and Competitors
Table 110. DHN Major Business
Table 111. DHN Inactivated Porcine Parvovirus Vaccine Product and Services
Table 112. DHN Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. DHN Recent Developments/Updates
Table 114. DHN Competitive Strengths & Weaknesses
Table 115. China Animal Husbandy Industry Basic Information, Manufacturing Base and Competitors
Table 116. China Animal Husbandy Industry Major Business
Table 117. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Product and Services
Table 118. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. China Animal Husbandy Industry Recent Developments/Updates
Table 120. China Animal Husbandy Industry Competitive Strengths & Weaknesses
Table 121. Qilu Animal Health Products Factorys Basic Information, Manufacturing Base and Competitors
Table 122. Qilu Animal Health Products Factorys Major Business
Table 123. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Product and Services
Table 124. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Qilu Animal Health Products Factorys Recent Developments/Updates
Table 126. Qilu Animal Health Products Factorys Competitive Strengths & Weaknesses
Table 127. Shandong HuaHong Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 128. Shandong HuaHong Biological Engineering Major Business
Table 129. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Product and Services
Table 130. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Shandong HuaHong Biological Engineering Recent Developments/Updates
Table 132. Shandong HuaHong Biological Engineering Competitive Strengths & Weaknesses
Table 133. Shanghai Hile Biological Basic Information, Manufacturing Base and Competitors
Table 134. Shanghai Hile Biological Major Business
Table 135. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Product and Services
Table 136. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Shanghai Hile Biological Recent Developments/Updates
Table 138. Shanghai Hile Biological Competitive Strengths & Weaknesses
Table 139. Liaoning Yikang Biological Basic Information, Manufacturing Base and Competitors
Table 140. Liaoning Yikang Biological Major Business
Table 141. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Product and Services
Table 142. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Liaoning Yikang Biological Recent Developments/Updates
Table 144. Jilin Zhengye Biological Product Basic Information, Manufacturing Base and Competitors
Table 145. Jilin Zhengye Biological Product Major Business
Table 146. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Product and Services
Table 147. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 148. Inactivated Porcine Parvovirus Vaccine Raw Material
Table 149. Key Manufacturers of Inactivated Porcine Parvovirus Vaccine Raw Materials
Table 150. Inactivated Porcine Parvovirus Vaccine Typical Distributors
Table 151. Inactivated Porcine Parvovirus Vaccine Typical Customers
Table 1. World Inactivated Porcine Parvovirus Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Inactivated Porcine Parvovirus Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Inactivated Porcine Parvovirus Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Inactivated Porcine Parvovirus Vaccine Production by Region (2017-2022) & (M Doses)
Table 7. World Inactivated Porcine Parvovirus Vaccine Production by Region (2023-2028) & (M Doses)
Table 8. World Inactivated Porcine Parvovirus Vaccine Production Market Share by Region (2017-2022)
Table 9. World Inactivated Porcine Parvovirus Vaccine Production Market Share by Region (2023-2028)
Table 10. World Inactivated Porcine Parvovirus Vaccine Average Price by Region (2017-2022) & (US$/K Doses)
Table 11. World Inactivated Porcine Parvovirus Vaccine Average Price by Region (2023-2028) & (US$/K Doses)
Table 12. Inactivated Porcine Parvovirus Vaccine Major Market Trends
Table 13. World Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (M Doses)
Table 14. World Inactivated Porcine Parvovirus Vaccine Consumption by Region (2017-2022) & (M Doses)
Table 15. World Inactivated Porcine Parvovirus Vaccine Consumption Forecast by Region (2023-2028) & (M Doses)
Table 16. World Inactivated Porcine Parvovirus Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Inactivated Porcine Parvovirus Vaccine Producers in 2021
Table 18. World Inactivated Porcine Parvovirus Vaccine Production by Manufacturer (2017-2022) & (M Doses)
Table 19. Production Market Share of Key Inactivated Porcine Parvovirus Vaccine Producers in 2021
Table 20. World Inactivated Porcine Parvovirus Vaccine Average Price by Manufacturer (2017-2022) & (US$/K Doses)
Table 21. Global Inactivated Porcine Parvovirus Vaccine Company Evaluation Quadrant
Table 22. World Inactivated Porcine Parvovirus Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Inactivated Porcine Parvovirus Vaccine Production Site of Key Manufacturer
Table 24. Inactivated Porcine Parvovirus Vaccine Market: Company Product Type Footprint
Table 25. Inactivated Porcine Parvovirus Vaccine Market: Company Product Application Footprint
Table 26. Inactivated Porcine Parvovirus Vaccine Competitive Factors
Table 27. Inactivated Porcine Parvovirus Vaccine New Entrant and Capacity Expansion Plans
Table 28. Inactivated Porcine Parvovirus Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Inactivated Porcine Parvovirus Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Inactivated Porcine Parvovirus Vaccine Production Comparison, (2017 & 2021 & 2028) & (M Doses)
Table 31. United States VS China Inactivated Porcine Parvovirus Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (M Doses)
Table 32. Major Manufacturer of Inactivated Porcine Parvovirus Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Inactivated Porcine Parvovirus Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Inactivated Porcine Parvovirus Vaccine Production by Domestic Manufacturer, (2017-2022) & (M Doses)
Table 36. United States Inactivated Porcine Parvovirus Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Inactivated Porcine Parvovirus Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Inactivated Porcine Parvovirus Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Inactivated Porcine Parvovirus Vaccine Production by Domestic Manufacturer, (2017-2022) & (M Doses)
Table 41. China Inactivated Porcine Parvovirus Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Inactivated Porcine Parvovirus Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Inactivated Porcine Parvovirus Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Inactivated Porcine Parvovirus Vaccine Production by Domestic Manufacturer, (2017-2022) & (M Doses)
Table 46. Rest of World Inactivated Porcine Parvovirus Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Inactivated Porcine Parvovirus Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Inactivated Porcine Parvovirus Vaccine Production by Type (2017-2022) & (M Doses)
Table 49. World Inactivated Porcine Parvovirus Vaccine Production by Type (2023-2028) & (M Doses)
Table 50. World Inactivated Porcine Parvovirus Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Inactivated Porcine Parvovirus Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Inactivated Porcine Parvovirus Vaccine Average Price by Type (2017-2022) & (US$/K Doses)
Table 53. World Inactivated Porcine Parvovirus Vaccine Average Price by Type (2023-2028) & (US$/K Doses)
Table 54. World Inactivated Porcine Parvovirus Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Inactivated Porcine Parvovirus Vaccine Production by Application (2017-2022) & (M Doses)
Table 56. World Inactivated Porcine Parvovirus Vaccine Production by Application (2023-2028) & (M Doses)
Table 57. World Inactivated Porcine Parvovirus Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Inactivated Porcine Parvovirus Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Inactivated Porcine Parvovirus Vaccine Average Price by Application (2017-2022) & (US$/K Doses)
Table 60. World Inactivated Porcine Parvovirus Vaccine Average Price by Application (2023-2028) & (US$/K Doses)
Table 61. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 62. Merck Animal Health Major Business
Table 63. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Product and Services
Table 64. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Merck Animal Health Recent Developments/Updates
Table 66. Merck Animal Health Competitive Strengths & Weaknesses
Table 67. HIPRA Basic Information, Manufacturing Base and Competitors
Table 68. HIPRA Major Business
Table 69. HIPRA Inactivated Porcine Parvovirus Vaccine Product and Services
Table 70. HIPRA Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. HIPRA Recent Developments/Updates
Table 72. HIPRA Competitive Strengths & Weaknesses
Table 73. Zoetis Basic Information, Manufacturing Base and Competitors
Table 74. Zoetis Major Business
Table 75. Zoetis Inactivated Porcine Parvovirus Vaccine Product and Services
Table 76. Zoetis Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Zoetis Recent Developments/Updates
Table 78. Zoetis Competitive Strengths & Weaknesses
Table 79. Ceva Basic Information, Manufacturing Base and Competitors
Table 80. Ceva Major Business
Table 81. Ceva Inactivated Porcine Parvovirus Vaccine Product and Services
Table 82. Ceva Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Ceva Recent Developments/Updates
Table 84. Ceva Competitive Strengths & Weaknesses
Table 85. Bioveta Basic Information, Manufacturing Base and Competitors
Table 86. Bioveta Major Business
Table 87. Bioveta Inactivated Porcine Parvovirus Vaccine Product and Services
Table 88. Bioveta Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Bioveta Recent Developments/Updates
Table 90. Bioveta Competitive Strengths & Weaknesses
Table 91. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 92. Boehringer Ingelheim Major Business
Table 93. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Product and Services
Table 94. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Boehringer Ingelheim Recent Developments/Updates
Table 96. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 97. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 98. Harbin Pharmaceutical Group Major Business
Table 99. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Product and Services
Table 100. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Harbin Pharmaceutical Group Recent Developments/Updates
Table 102. Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
Table 103. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 104. Wuhan Keqian Biology Major Business
Table 105. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Product and Services
Table 106. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Wuhan Keqian Biology Recent Developments/Updates
Table 108. Wuhan Keqian Biology Competitive Strengths & Weaknesses
Table 109. DHN Basic Information, Manufacturing Base and Competitors
Table 110. DHN Major Business
Table 111. DHN Inactivated Porcine Parvovirus Vaccine Product and Services
Table 112. DHN Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. DHN Recent Developments/Updates
Table 114. DHN Competitive Strengths & Weaknesses
Table 115. China Animal Husbandy Industry Basic Information, Manufacturing Base and Competitors
Table 116. China Animal Husbandy Industry Major Business
Table 117. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Product and Services
Table 118. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. China Animal Husbandy Industry Recent Developments/Updates
Table 120. China Animal Husbandy Industry Competitive Strengths & Weaknesses
Table 121. Qilu Animal Health Products Factorys Basic Information, Manufacturing Base and Competitors
Table 122. Qilu Animal Health Products Factorys Major Business
Table 123. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Product and Services
Table 124. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Qilu Animal Health Products Factorys Recent Developments/Updates
Table 126. Qilu Animal Health Products Factorys Competitive Strengths & Weaknesses
Table 127. Shandong HuaHong Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 128. Shandong HuaHong Biological Engineering Major Business
Table 129. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Product and Services
Table 130. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Shandong HuaHong Biological Engineering Recent Developments/Updates
Table 132. Shandong HuaHong Biological Engineering Competitive Strengths & Weaknesses
Table 133. Shanghai Hile Biological Basic Information, Manufacturing Base and Competitors
Table 134. Shanghai Hile Biological Major Business
Table 135. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Product and Services
Table 136. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Shanghai Hile Biological Recent Developments/Updates
Table 138. Shanghai Hile Biological Competitive Strengths & Weaknesses
Table 139. Liaoning Yikang Biological Basic Information, Manufacturing Base and Competitors
Table 140. Liaoning Yikang Biological Major Business
Table 141. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Product and Services
Table 142. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Liaoning Yikang Biological Recent Developments/Updates
Table 144. Jilin Zhengye Biological Product Basic Information, Manufacturing Base and Competitors
Table 145. Jilin Zhengye Biological Product Major Business
Table 146. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Product and Services
Table 147. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 148. Inactivated Porcine Parvovirus Vaccine Raw Material
Table 149. Key Manufacturers of Inactivated Porcine Parvovirus Vaccine Raw Materials
Table 150. Inactivated Porcine Parvovirus Vaccine Typical Distributors
Table 151. Inactivated Porcine Parvovirus Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Inactivated Porcine Parvovirus Vaccine Picture
Figure 2. World Inactivated Porcine Parvovirus Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Inactivated Porcine Parvovirus Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Inactivated Porcine Parvovirus Vaccine Production (2017-2028) & (M Doses)
Figure 5. World Inactivated Porcine Parvovirus Vaccine Average Price (2017-2028) & (US$/K Doses)
Figure 6. World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Inactivated Porcine Parvovirus Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Inactivated Porcine Parvovirus Vaccine Production (2017-2028) & (M Doses)
Figure 9. Europe Inactivated Porcine Parvovirus Vaccine Production (2017-2028) & (M Doses)
Figure 10. China Inactivated Porcine Parvovirus Vaccine Production (2017-2028) & (M Doses)
Figure 11. Japan Inactivated Porcine Parvovirus Vaccine Production (2017-2028) & (M Doses)
Figure 12. Inactivated Porcine Parvovirus Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Inactivated Porcine Parvovirus Vaccine Demand (2017-2028) & (M Doses)
Figure 15. World Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028) & (M Doses)
Figure 17. China Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028) & (M Doses)
Figure 18. Europe Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028) & (M Doses)
Figure 19. Japan Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028) & (M Doses)
Figure 20. South Korea Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028) & (M Doses)
Figure 21. ASEAN Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028) & (M Doses)
Figure 22. India Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028) & (M Doses)
Figure 23. Producer Shipments of Inactivated Porcine Parvovirus Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Inactivated Porcine Parvovirus Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Inactivated Porcine Parvovirus Vaccine Markets in 2021
Figure 26. United States VS China: Inactivated Porcine Parvovirus Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Inactivated Porcine Parvovirus Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Inactivated Porcine Parvovirus Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Inactivated Porcine Parvovirus Vaccine in United States
Figure 30. Key Producers and Market Share of Inactivated Porcine Parvovirus Vaccine in China
Figure 31. Key Producers and Market Share of Inactivated Porcine Parvovirus Vaccine in Rest of World
Figure 32. World Inactivated Porcine Parvovirus Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Type in 2021
Figure 34. <107.0 TCID50/mL
Figure 35. ?107.0 TCID50/mL
Figure 36. World Inactivated Porcine Parvovirus Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Inactivated Porcine Parvovirus Vaccine Average Price by Type (2017-2028) & (US$/K Doses)
Figure 39. World Inactivated Porcine Parvovirus Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Application in 2021
Figure 41. Sows
Figure 42. Gilts
Figure 43. Boars
Figure 44. World Inactivated Porcine Parvovirus Vaccine Production Market Share by Application (2017-2028)
Figure 45. World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Application (2017-2028)
Figure 46. World Inactivated Porcine Parvovirus Vaccine Average Price by Application (2017-2028) & (US$/K Doses)
Figure 47. Manufacturing Cost Structure Analysis of Inactivated Porcine Parvovirus Vaccine in 2021
Figure 48. Manufacturing Process Analysis of Inactivated Porcine Parvovirus Vaccine
Figure 49. Inactivated Porcine Parvovirus Vaccine Industrial Chain
Figure 50. Distribution Channel Breakdown for Inactivated Porcine Parvovirus Vaccine Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Inactivated Porcine Parvovirus Vaccine Picture
Figure 2. World Inactivated Porcine Parvovirus Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Inactivated Porcine Parvovirus Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Inactivated Porcine Parvovirus Vaccine Production (2017-2028) & (M Doses)
Figure 5. World Inactivated Porcine Parvovirus Vaccine Average Price (2017-2028) & (US$/K Doses)
Figure 6. World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Inactivated Porcine Parvovirus Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Inactivated Porcine Parvovirus Vaccine Production (2017-2028) & (M Doses)
Figure 9. Europe Inactivated Porcine Parvovirus Vaccine Production (2017-2028) & (M Doses)
Figure 10. China Inactivated Porcine Parvovirus Vaccine Production (2017-2028) & (M Doses)
Figure 11. Japan Inactivated Porcine Parvovirus Vaccine Production (2017-2028) & (M Doses)
Figure 12. Inactivated Porcine Parvovirus Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Inactivated Porcine Parvovirus Vaccine Demand (2017-2028) & (M Doses)
Figure 15. World Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028) & (M Doses)
Figure 17. China Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028) & (M Doses)
Figure 18. Europe Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028) & (M Doses)
Figure 19. Japan Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028) & (M Doses)
Figure 20. South Korea Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028) & (M Doses)
Figure 21. ASEAN Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028) & (M Doses)
Figure 22. India Inactivated Porcine Parvovirus Vaccine Consumption (2017-2028) & (M Doses)
Figure 23. Producer Shipments of Inactivated Porcine Parvovirus Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Inactivated Porcine Parvovirus Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Inactivated Porcine Parvovirus Vaccine Markets in 2021
Figure 26. United States VS China: Inactivated Porcine Parvovirus Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Inactivated Porcine Parvovirus Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Inactivated Porcine Parvovirus Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Inactivated Porcine Parvovirus Vaccine in United States
Figure 30. Key Producers and Market Share of Inactivated Porcine Parvovirus Vaccine in China
Figure 31. Key Producers and Market Share of Inactivated Porcine Parvovirus Vaccine in Rest of World
Figure 32. World Inactivated Porcine Parvovirus Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Type in 2021
Figure 34. <107.0 TCID50/mL
Figure 35. ?107.0 TCID50/mL
Figure 36. World Inactivated Porcine Parvovirus Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Inactivated Porcine Parvovirus Vaccine Average Price by Type (2017-2028) & (US$/K Doses)
Figure 39. World Inactivated Porcine Parvovirus Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Application in 2021
Figure 41. Sows
Figure 42. Gilts
Figure 43. Boars
Figure 44. World Inactivated Porcine Parvovirus Vaccine Production Market Share by Application (2017-2028)
Figure 45. World Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Application (2017-2028)
Figure 46. World Inactivated Porcine Parvovirus Vaccine Average Price by Application (2017-2028) & (US$/K Doses)
Figure 47. Manufacturing Cost Structure Analysis of Inactivated Porcine Parvovirus Vaccine in 2021
Figure 48. Manufacturing Process Analysis of Inactivated Porcine Parvovirus Vaccine
Figure 49. Inactivated Porcine Parvovirus Vaccine Industrial Chain
Figure 50. Distribution Channel Breakdown for Inactivated Porcine Parvovirus Vaccine Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
